BridgePort Financial Solutions’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Sell
3,081
-88
-3% -$11.6K 0.1% 157
2026
Q1
$442K Sell
3,169
-112
-3% -$15.7K 0.13% 137
2025
Q4
$403K Sell
3,281
-163
-5% -$19.8K 0.11% 148
2025
Q3
$382K Sell
3,444
-3,610
-51% -$410K 0.1% 153
2025
Q2
$782K Buy
7,054
+2,928
+71% +$312K 0.26% 79
2025
Q1
$462K Buy
4,126
+260
+7% +$26.8K 0.21% 98
2024
Q4
$433K Buy
+3,866
New +$348K 0.2% 100

Other funds holding GILD

BridgePort Financial Solutions's GILD Position: Q2 2026 in Review

BridgePort Financial Solutions reduced its Gilead Sciences (GILD) stake by 2.8% in Q2 2026, selling an estimated $11.6K and leaving 3,081 shares worth $389K. The position accounts for 0.1% of the portfolio, ranked #157.

BridgePort Financial Solutions first reported a position in GILD in Q4 2024 and has held it in 7 quarters since. The position peaked at $782K in Q2 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • BridgePort Financial Solutions held 3,081 shares of Gilead Sciences worth $389K as of Q2 2026.
  • BridgePort Financial Solutions sold 88 Gilead Sciences shares in Q2 2026, an estimated $11.6K.
  • Gilead Sciences made up 0.1% of BridgePort Financial Solutions's portfolio in Q2 2026, its #157 holding.
  • BridgePort Financial Solutions first reported a position in Gilead Sciences in Q4 2024 and has held it in 7 quarters since.
  • BridgePort Financial Solutions's Gilead Sciences position peaked at $782K in Q2 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on BridgePort Financial Solutions's 13F filing for Q2 2026, filed 24 Jul 2026.